NEUROTABS potassium iodate 253 micrograms tablet bottle

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

potassium iodate, Quantity: 253 microgram (Equivalent: iodine, Qty 150 microgram)

Disponível em:

AFT Pharmaceuticals Pty Ltd

DCI (Denominação Comum Internacional):

potassium iodate

Forma farmacêutica:

Tablet, uncoated

Composição:

Excipient Ingredients: microcrystalline cellulose; calcium hydrogen phosphate; croscarmellose sodium; magnesium stearate; silicon dioxide

Via de administração:

Oral

Unidades em pacote:

90 tablets

Tipo de prescrição:

Not scheduled. Not considered by committee

Indicações terapêuticas:

For the prophylaxis and treatment of iodine deficiency disorders.,Iodine requirement is increased during the first 20 weeks of pregnancy. Iodine is essential for the production of thyroid hormones which are critical for the growth and normal healthy development of a baby's brain, visual motor skills and hearing. Iodine supports the development of normal intelligence and IQ. For healthy pregnancy support.

Resumo do produto:

Visual Identification: White to off-white, circular, flat faced, bevelled edged, uncoated tablet having debossing 'L74' on one side and a plain surface on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Status de autorização:

Licence status A

Data de autorização:

2013-05-03